No Data
Private Companies Among C.Q. Pharmaceutical Holding Co., Ltd.'s (SZSE:000950) Largest Shareholders, Saw Gain in Holdings Value After Stock Jumped 4.8% Last Week
Heavy Pharmaceuticals Holdings: Report for the third quarter of 2024
c.q. pharmaceutical holding (000950.SZ): net income in the third quarter was 54.137 million yuan, a year-on-year increase of 1269.44%.
C.q. Pharmaceutical Holding (000950.SZ) announced its third-quarter report on October 24th. In the third quarter of 2024, the company achieved a revenue of 19.913 billion yuan, an increase of 12.70% year-on-year; the net income attributable to shareholders of the listed company was 54.137 million yuan, an increase of 1,269.44% year-on-year; the net income after deducting non-recurring gains and losses was 58.7922 million yuan, an increase of 1,342.83% year-on-year; and the basic earnings per share was 0.03 yuan/share.
c.q. pharmaceutical holding (000950.SZ) released its performance for the first three quarters, with a net income of 0.292 billion yuan, a year-on-year decrease of 43.54%.
c.q. pharmaceutical holding (000950.SZ) released the third quarter report of 2024, achieving revenue in the first three quarters...
C.Q. Pharmaceutical Holding's (SZSE:000950) Five-year Decline in Earnings Translates Into Losses for Shareholders
c.q. pharmaceutical holding (000950.SZ): Chongqing Pharmaceutical shares plans to register and issue perpetual bonds of no more than 2 billion yuan.
On September 23, c.q. pharmaceutical holding (000950.SZ) announced that in order to further broaden its financing channels, optimize its financing structure and asset-liability structure, and meet the capital needs for the further development of Chongqing Medicine (Group) Co., Ltd., a subsidiary of c.q. pharmaceutical holding, the c.q. pharmaceutical holding plans to register and issue perpetual bonds (including but not limited to perpetual medium-term notes, renewable debt products, etc.), with a registered issuance size not exceeding RMB 2 billion. This matter still needs to be submitted for review by the company's shareholders' meeting.
The Returns At C.Q. Pharmaceutical Holding (SZSE:000950) Aren't GrowingNo Data
No Data
